Why it matters: These outbreaks — which have been especially large in Washington, Oregon and Texas — were predictable. A 2018 study of vaccination rates identified a dozen likely hotspots, two of which have now seen eruptions of this preventable illness.
This tells you a lot about what matters to Democratic primary voters: "1st question for Beto O'Rourke as a 2020 candidate is on health care," NBC's Alex Seitz-Wald reported yesterday from Iowa.
What he's saying: O'Rourke didn't sign on to single-payer legislation when he was in the House, but he made some Medicare-for-All-adjacent comments early in early his Senate run, but he's not talking about Medicare for All now.
As part of its plan to lower prescription drug prices, the Trump administration wants to force a major change in the way industry middlemen make their money. But that change is already happening naturally — and drug prices aren't falling.
The big picture: Pharmaceutical companies place the blame for high drug prices on pharmacy benefit managers and their complex system of rebates. The Trump administration largely agrees with that assessment, and has proposed a major overhaul that would make rebates a lot less lucrative for PBMs.
After what seemed like a million incremental announcements, the Food and Drug Administration formally released its proposal yesterday to restrict the sale of flavored vape products, in the hopes of curbing their popularity among teens.
The big picture is pretty much what we expected: Physical stores must either keep out everyone younger than 18 or keep their e-cigarette supplies in a separate room inaccessible to underage customers. Online retailers must use age-verification tools.
